Open Access Institutional Repository
at Robert Gordon University
View Item 
  •   OpenAIR Home
  • Health and social care
  • Pharmacy and life sciences
  • Journal articles (Pharmacy and life sciences)
  • View Item
  •   OpenAIR Home
  • Health and social care
  • Pharmacy and life sciences
  • Journal articles (Pharmacy and life sciences)
  • View Item
    • Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach.

    View/Open
    Wainwright PRP 2015 Pharmacological.pdf (2.281Mb)
    Date
    2015-06
    Author
    Walsh, Sarah K.
    Hepburn, Claire Y.
    Keown, Oliver
    Astrand, Annika
    Lindblom, Anna
    Ryberg, Erik
    Hjorth, Stephan
    Leslie, Stephen J.
    Greasley, Peter J.
    Wainwright, Cherry L.
    Metadata
    Show full item record
    Citation
    WALSH, S. K., HEPBURN, C. Y., KEOWN, O., ASTRAND, A., LINDBLOM, A., RYBERG, E., HJORTH, S., LESLIE, S. J., GREASLEY, P. J. and WAINWRIGHT, C. L., 2015. Pharmacological profiling of the hemodynamic effects of cannabinoid ligands: a combined in vitro and in vivo approach. Pharmacology Research & Perspectives, [online] 3 (3), article 143. Available from: http://onlinelibrary.wiley.com/doi/10.1111/prp2.2015.3.issue-3/issuetoc [Accessed 9 July 2015]
    Abstract
    The receptors mediating the hemodynamic responses to cannabinoids are not clearly defined due to the multifarious pharmacology of many commonly used cannabinoid ligands. While both CB1 and TRPV1 receptors are implicated, G protein-coupled receptor 55 (GPR55) may also mediate some of the hemodynamic effects of several atypical cannabinoid ligands. The present studies attempted to unravel the pharmacology underlying the in vivo hemodynamic responses to ACEA (CB1 agonist), O-1602 (GPR55 agonist), AM251 (CB1 antagonist), and cannabidiol (CBD; GPR55 antagonist). Agonist and antagonist profiles of each ligand were determined by ligand-induced GTPcS binding in membrane preparations expressing rat and mouse CB1 and GPR55 receptors. Blood pressure responses to ACEA and O-1602 were recorded in anesthetized and conscious mice (wild type, CB1 / and GPR55 / ) and rats in the absence and presence of AM251 and CBD. ACEA demonstrated GTPcS activation at both receptors, while O-1602 only activated GPR55. AM251 exhibited antagonist activity at CB1 and agonist activity at GPR55, while CBD demonstrated selective antagonist activity at GPR55. The depressor response to ACEA was blocked by AM251 and attenuated by CBD, while O-1602 did not induce a depressor response. AM251 caused a depressor response that was absent in GPR55 / mice but enhanced by CBD, while CBD caused a small vasodepressor response that persisted in GPR55 / mice. Our findings show that assessment of the pharmacological profile of receptor activation by cannabinoid ligands in in vitro studies alongside in vivo functional studies is essential to understand the role of cannabinoids in hemodynamic control.
    Publisher link
    http://dx.doi.org/10.1002/prp2.143
    Permalink for this record
    http://hdl.handle.net/10059/1235
    Collections in which this item appears
    • Journal articles (Pharmacy and life sciences)

    Disclaimer | Freedom of Information | Privacy Statement | Takedown Policy | Contact Us | Information about OpenAIR | Copyright ©2015

    Robert Gordon University, Garthdee House, Garthdee Road, Aberdeen, AB10 7QB, Scotland, UK: a Scottish charity, registration No. SC013781

     

     

    Browse

    All of OpenAIRCommunities & CollectionsAuthorsTypesSubjectsBy Issue DateTitlesThis CollectionAuthorsTypesSubjectsBy Issue DateTitles

    My Account

    LoginRegister

    Statistics

    View Google Analytics Statistics

    Disclaimer | Freedom of Information | Privacy Statement | Takedown Policy | Contact Us | Information about OpenAIR | Copyright ©2015

    Robert Gordon University, Garthdee House, Garthdee Road, Aberdeen, AB10 7QB, Scotland, UK: a Scottish charity, registration No. SC013781